GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TerrAscend Corp (TSX:TSND) » Definitions » EV-to-EBIT

TerrAscend (TSX:TSND) EV-to-EBIT : -30.98 (As of Apr. 29, 2024)


View and export this data going back to 2017. Start your Free Trial

What is TerrAscend EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, TerrAscend's Enterprise Value is C$980.2 Mil. TerrAscend's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-31.6 Mil. Therefore, TerrAscend's EV-to-EBIT for today is -30.98.

The historical rank and industry rank for TerrAscend's EV-to-EBIT or its related term are showing as below:

TSX:TSND' s EV-to-EBIT Range Over the Past 10 Years
Min: -57.95   Med: -6.92   Max: 21.85
Current: -30.98

During the past 8 years, the highest EV-to-EBIT of TerrAscend was 21.85. The lowest was -57.95. And the median was -6.92.

TSX:TSND's EV-to-EBIT is ranked worse than
100% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.12 vs TSX:TSND: -30.98

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. TerrAscend's Enterprise Value for the quarter that ended in Dec. 2023 was C$942.6 Mil. TerrAscend's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-31.6 Mil. TerrAscend's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -3.36%.


TerrAscend EV-to-EBIT Historical Data

The historical data trend for TerrAscend's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TerrAscend EV-to-EBIT Chart

TerrAscend Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial -2.43 -15.45 23.97 -1.95 -29.61

TerrAscend Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.95 -2.37 -2.49 18.61 -29.61

Competitive Comparison of TerrAscend's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, TerrAscend's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TerrAscend's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TerrAscend's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where TerrAscend's EV-to-EBIT falls into.



TerrAscend EV-to-EBIT Calculation

TerrAscend's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=980.245/-31.637
=-30.98

TerrAscend's current Enterprise Value is C$980.2 Mil.
TerrAscend's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-31.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TerrAscend  (TSX:TSND) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

TerrAscend's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-31.637/942.6096
=-3.36 %

TerrAscend's Enterprise Value for the quarter that ended in Dec. 2023 was C$942.6 Mil.
TerrAscend's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-31.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TerrAscend EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of TerrAscend's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


TerrAscend (TSX:TSND) Business Description

Traded in Other Exchanges
Address
3610 Mavis Road, Mississauga, ON, CAN, L5C 1W2
TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.

TerrAscend (TSX:TSND) Headlines

No Headlines